Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-12-004229

Sr. VP, Drug Development sold 6,844 shares at $4.70 ($32,187)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Koya Keizo Sr. VP, Drug Development 2012-03-01 Sale −6,844 $4.70 $32,187 12,999 D: show line 1 in the form
Open-market sales · 6,844 sh · avg $4.70 · $32,187
Loading xslF345X03/edgar.xml…